ribavirin has been researched along with exenatide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Banasch, M; Ellrichmann, M; Meier, JJ; Schmidt, WE; Schrader, H; Vollmer, K | 1 |
1 review(s) available for ribavirin and exenatide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ribavirin and exenatide
| Article | Year |
|---|---|
Sustained virological response during exenatide treatment in a patient with hepatitis C and nonalcoholic steatohepatitis.
Topics: Antiviral Agents; Drug Therapy, Combination; Exenatide; Fatty Liver; Hepatitis C, Chronic; Humans; Hypoglycemic Agents; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Peptides; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Venoms; Viral Load | 2009 |